Type of Care:
Substance use treatment Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Hospital inpatient/24-hour hospital inpatient
Facility Type:
Psychiatric hospital
Pharmacotherapies:
Chlorpromazine Haloperidol Aripiprazole Clozapine IIoperidone Lurasidone Olanzapine Olanzapine/Fluoxetine combination Paliperidone Quetiapine Risperidone Ziprasidone Nicotine replacement Antipsychotics used in treatment of SMI
Treatment Approaches:
Activity therapy Individual psychotherapy Telemedicine/telehealth therapy Abnormal involuntary movement scale
Emergency Mental Health Services:
Psychiatric emergency onsite services
Facility Operation (e.g., Private, Public):
Private for-profit organization
Special Programs/Groups Offered:
Clients with co-occurring mental and substance use disorders Persons 18 and older with serious mental illness (SMI)
Assessment/Pre-treatment:
Screening for tobacco use
Testing:
TB screening Metabolic syndrome monitoring Laboratory testing
Facility Smoking Policy :
Smoking not permitted
Age Groups Accepted:
Young Adults Adults
Facility Vaping Policy:
Vaping not permitted
Ancillary Services:
Case management service Suicide prevention services